Search
for
Sort by
Research 181–210 of 1000+
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Efectos de la terapia combinada del D-004 y el Finasteride sobre la hiperplasia de próstata inducida por testosterona en ratas
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis
- Chromatographic methods for determination of finasteride and tamsulosin hydrochloride and in presence of finasteride degradation product
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation
- Poster Abstracts
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Effect of minoxidil on blood pressure and hemodynamics in severe hypertension
- Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations
- Anaemia and skin disease
- <i>In vivo</i> and <i>in silico</i> evaluation of the ameliorative effect of hesperidin on finasteride-induced testicular oxidative stress in Wistar rats
- Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review
- Principles of Therapy of Skin Diseases
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- LY191704: a selective, nonsteroidal inhibitor of human steroid 5 alpha-reductase type 1.
- Incomplete Recovery of Erectile Function in Rat after Discontinuation of Dual 5‐Alpha Reductase Inhibitor Therapy
- Current treatment of BPH
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Scientific augmentation of BPH and its treatment in Unani medicine the review
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
- Optimization of LC method for the determination of testosterone and epitestosterone in urine samples in view of biomedical studies and anti-doping research studies
- Hyperadrenocorticism in Ferrets
- Serial Hydrolysis for the Simultaneous Analysis of Catecholamines and Steroids in the Urine of Patients with Alopecia Areata
- Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media